{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:12:37Z","timestamp":1789974757499,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.cca.2006.09.028","type":"journal-article","created":{"date-parts":[[2006,10,12]],"date-time":"2006-10-12T11:29:21Z","timestamp":1160652561000},"page":"213-220","source":"Crossref","is-referenced-by-count":57,"title":["Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: Correlation with low molecular AGE adduct clearance"],"prefix":"10.1016","volume":"377","author":[{"given":"Alejandro","family":"Gugliucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Mehlhaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Kinugasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Hermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2006.09.028_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000085416","article-title":"Hemodialysis \u2014 from early days to tomorrow","volume":"149","author":"Ritz","year":"2005","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.cca.2006.09.028_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccl.2005.03.002","article-title":"Pathophysiology of cardiovascular disease and renal failure","volume":"23","author":"Dikow","year":"2005","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.cca.2006.09.028_bib3","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1111\/j.1523-1755.2005.09508.x","article-title":"Evaluation and treatment of coronary artery disease in patients with end-stage renal disease","author":"McCullough","year":"2005","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.cca.2006.09.028_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccl.2005.03.002","article-title":"Pathophysiology of cardiovascular disease and renal failure","volume":"23","author":"Dikow","year":"2005","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.cca.2006.09.028_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.47102\/annals-acadmedsg.V34N1p31","article-title":"Hyperlipidaemia in chronic kidney disease","volume":"34","author":"Chan","year":"2005","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.cca.2006.09.028_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1194\/jlr.R500014-JLR200","article-title":"The pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part IV: the 1984 coronary primary prevention trial ends it-almost","volume":"47","author":"Steinberg","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2006.09.028_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0009-2797(93)90038-Z","article-title":"Is paraoxonase related to atherosclerosis","volume":"87","author":"Mackness","year":"1993","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.cca.2006.09.028_bib8","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.ATV.0000222924.62641.aa","article-title":"Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome","volume":"26","author":"Mackness","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2006.09.028_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0009-2797(99)00049-6","article-title":"On the physiological role(s) of the paraoxonases","volume":"119\u2013120","author":"La Du","year":"1999","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.cca.2006.09.028_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.mol.0000174398.84185.0f","article-title":"Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences","volume":"16","author":"Aviram","year":"2005","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cca.2006.09.028_bib11","first-page":"392","article-title":"Protein homocysteinylation: a new mechanism of atherogenesis?","volume":"59","author":"Beltowski","year":"2005","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"10.1016\/j.cca.2006.09.028_bib12","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.freeradbiomed.2004.06.030","article-title":"Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development","volume":"37","author":"Aviram","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.cca.2006.09.028_bib13","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(94)92935-1","article-title":"Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure","volume":"343","author":"Makita","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2006.09.028_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF00403957","article-title":"Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells","volume":"39","author":"Gugliucci","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2006.09.028_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.jrn.2006.04.012","article-title":"Advanced glycation end products in renal failure","volume":"16","author":"Thornalley","year":"2006","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.cca.2006.09.028_bib16","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00467-005-2011-9","article-title":"Glycation free adduct accumulation in renal disease: the new AGE","volume":"20","author":"Thornalley","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.cca.2006.09.028_bib17","first-page":"813","article-title":"Serum paraoxonase activity in uremic predialysis and hemodialysis patients","volume":"17","author":"Dirican","year":"2004","journal-title":"J Nephrol"},{"key":"10.1016\/j.cca.2006.09.028_bib18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.MAT.0000066256.19852.29","article-title":"Paraoxonase activity and paraoxonase 1 gene polymorphism in patients with uremia","volume":"49","author":"Biasioli","year":"2003","journal-title":"ASAIO J"},{"key":"10.1016\/j.cca.2006.09.028_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0021-9150(98)00286-X","article-title":"HDL composition and HDL antioxidant capacity in patients on regular haemodialysis","volume":"143","author":"Hasselwander","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2006.09.028_bib20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0022-2275(20)38354-1","article-title":"A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent","volume":"30","author":"el-Saadani","year":"1989","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2006.09.028_bib21","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/ndt\/12.7.1310","article-title":"Advanced oxidation protein products: novel uraemic toxins and pro-inflammatory mediators in chronic renal failure?","volume":"12","author":"Witko-Sarsat","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cca.2006.09.028_bib22","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1016\/S0021-9258(18)99007-1","article-title":"Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo","volume":"266","author":"Dyer","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2006.09.028_bib23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1073\/pnas.81.2.583","article-title":"Accelerated age-related browning of human collagen in diabetes mellitus","volume":"81","author":"Monnier","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2006.09.028_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1373\/49.4.581","article-title":"Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction","volume":"49","author":"Bhagavan","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2006.09.028_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cccn.2005.06.014","article-title":"Ischemia-modified albumin concentrations in cord blood: a case-control study in uncomplicated and complicated deliveries","volume":"362","author":"Gugliucci","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2006.09.028_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1749-6632.2002.tb02933.x","article-title":"Preservation of paraoxonase activity by wine flavonoids: possible role in protection of LDL from lipid peroxidation","volume":"957","author":"Fuhrman","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2006.09.028_bib27","first-page":"49","article-title":"Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans","volume":"28","author":"Aviram","year":"2002","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.cca.2006.09.028_bib28","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/clinchem\/37.7.1149","article-title":"Cholesterol distribution between high-density-lipoprotein subfractions HDL2 and HDL3 determined in serum by discontinuous gradient gel electrophoresis","volume":"37","author":"Atger","year":"1991","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2006.09.028_bib29","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.0894-0959.2004.17605.x","article-title":"Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg?","volume":"17","author":"Himmelfarb","year":"2004","journal-title":"Semin Dial"},{"key":"10.1016\/j.cca.2006.09.028_bib30","first-page":"813","article-title":"Serum paraoxonase activity in uremic predialysis and hemodialysis patients","volume":"17","author":"Dirican","year":"2004","journal-title":"J Nephrol"},{"key":"10.1016\/j.cca.2006.09.028_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.MAT.0000066256.19852.29","article-title":"Paraoxonase activity and paraoxonase 1 gene polymorphism in patients with uremia","volume":"49","author":"Biasioli","year":"2003","journal-title":"ASAIO J"},{"key":"10.1016\/j.cca.2006.09.028_bib32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/ndt\/18.3.463","article-title":"Uraemic toxins and cardiovascular disease","volume":"18","author":"Vanholder","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cca.2006.09.028_bib33","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: classification, concentration, and interindividual variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.cca.2006.09.028_bib34","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1373\/clinchem.2005.064212","article-title":"Influence of PON-1 polymorphisms on the association between serum paraoxonase 1 and homocysteinemia in a general population","volume":"52","author":"Murphy","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2006.09.028_bib35","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/ndt\/gfl007","article-title":"Respective role of uraemic toxins and myeloperoxidase in the uraemic state","volume":"21","author":"Capeillere-Blandin","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cca.2006.09.028_bib36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1755.2003.00741.x","article-title":"Effects of high-flux hemodialysis on oxidant stress","volume":"63","author":"Ward","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.cca.2006.09.028_bib37","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1046\/j.1525-1594.2003.07170.x","article-title":"Oxidant stress in hemodialysis patients: what are the determining factors?","volume":"27","author":"Ward","year":"2003","journal-title":"Artif Organs"},{"key":"10.1016\/j.cca.2006.09.028_bib38","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1196\/annals.1338.071","article-title":"Processing advanced glycation end product-modified albumin by the renal proximal tubule and the early pathogenesis of diabetic nephropathy","volume":"1043","author":"Ozdemir","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2006.09.028_bib39","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1177\/089686080502500603","article-title":"Measurement of protein glycation, glycated peptides, and glycation free adducts","volume":"25","author":"Thornalley","year":"2005","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.cca.2006.09.028_bib40","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1089\/rej.2006.9.264","article-title":"Prevention and repair of protein damage by the Maillard reaction in vivo","volume":"9","author":"Monnier","year":"2006","journal-title":"Rejuvenation Res"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898106006838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898106006838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T10:08:25Z","timestamp":1707300505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898106006838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":40,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0009898106006838"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2006.09.028","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}